tirzepatide from peptide sciences 15mg at ₹ 1800/vial | Mounjaro in Nagpur GLP-2 T 20mg (5 pack)

Tirzepatide is a novel, dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor agonist that is approved in the US as a treatment for type 2 diabetes and under development for long-term weight management, heart failure with preserved ejection fraction and related comorbidities, and nonalcoholic steatohepatitis

The same stepwise escalating-amount protocol applied

However, remember the 28-day rule

Wanleenuwat P, Iwanowski P, Kozubski W

Compounded GLP-1 medications are prescribed only when a licensed healthcare provider determines, based on an individual patients medical needs, that an FDA-approved drug is not appropriate or that a clinically significant difference exists, such as dosage form, strength, or excipient composition

Pancreatitis risk amplification Both alcohol and tirzepatide independently carry a small risk of pancreatitis